0951-3590

Gynecological Endocrinology

Informa UK (Taylor & Francis)

Health Score

0 Poor

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 290 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact290 DOIs
2

Attach ORCID iDs across 290 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact290 DOIs
3

Add license metadata to 287 records

License metadata tells indexers and readers how each article may be reused.

High impact287 DOIs

DOIs for this ISSN

Showing the top 5 of 290 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 RETRACTED ARTICLE: Effect of myo-inositol and melatonin vers… (10.3109/09513590.2015.1101444)
Abstract References ORCID License
199.56 98
2 Insulin resistance in obesity and polycystic ovary syndrome:… (10.3109/09513590.2015.1117069)
Abstract ORCID License
146.93 90
3 RETRACTED ARTICLE: The adjuvant effect of metformin and… (10.3109/09513590.2015.1037269)
Abstract References ORCID License
143.14 26
4 Endometrial thickness significantly affects clinical pregnan… (10.3109/09513590.2015.1136616)
Abstract ORCID License
142.73 79
5 Inositol’s and other nutraceuticals’ synergistic actions cou… (10.3109/09513590.2016.1144741)
Abstract ORCID License
142.32 78
6 Relationship between hyperandrogenism, obesity, inflammation… (10.3109/09513590.2016.1155208)
Abstract ORCID License
140.63 74
7 Results from the International Consensus Conference on myo-i… (10.3109/09513590.2015.1006616)
Abstract ORCID License
135.46 63
8 Supplementation during pregnancy: beliefs and science (10.3109/09513590.2016.1149161)
Abstract ORCID License
134.43 61
9 Dydrogesterone use in early pregnancy (10.3109/09513590.2015.1121982)
Abstract ORCID License
132.26 57
10 RETRACTED ARTICLE: Impact of unilateral versus bilateral lap… (10.3109/09513590.2015.1124262)
Abstract References ORCID License
132.22 20
11 Osteoporosis and cardiovascular disease: an update (10.3109/09513590.2015.1041908)
Abstract ORCID License
131.11 55
12 Letrozole versus clomiphene citrate in polycystic ovary synd… (10.3109/09513590.2015.1096337)
Abstract ORCID License
129.32 52
13 Visceral adiposity index as a predictor of clinical severity… (10.3109/09513590.2015.1111327)
Abstract ORCID License
129.32 52
14 The effect of endometrial thickness on the day of hCG admini… (10.3109/09513590.2015.1132304)
Abstract ORCID License
128.70 51
15 A systematic review of dydrogesterone for the treatment of r… (10.3109/09513590.2015.1006618)
Abstract ORCID License
128.07 50
16 Mood disorders and quality of life in polycystic ovary syndr… (10.3109/09513590.2015.1009437)
Abstract ORCID License
127.42 49
17 <scp>d</scp>-<i>chiro</i>-Inositol and alpha lipoic acid tre… (10.3109/09513590.2015.1014784)
Abstract ORCID License
126.76 48
18 Factors implicated in the initiation of human parturition in… (10.3109/09513590.2015.1076783)
Abstract ORCID License
126.76 48
19 The use of ovarian reserve markers in IVF clinical practice:… (10.3109/09513590.2015.1102879)
Abstract ORCID License
126.09 47
20 Evidence of the activation of unfolded protein response in g… (10.3109/09513590.2015.1062862)
Abstract ORCID License
124.71 45
21 Effect of treatment with myo-inositol on semen parameters of… (10.3109/09513590.2015.1080680)
Abstract ORCID License
124.71 45
22 Role of kisspeptin in polycystic ovary syndrome (PCOS) (10.3109/09513590.2016.1161019)
Abstract ORCID License
124.71 45
23 Hirsutism and oligomenorrhea are appropriate screening crite… (10.3109/09513590.2015.1025380)
Abstract ORCID License
122.51 42
24 High-visfatin levels in women with polycystic ovary syndrome… (10.3109/09513590.2015.1056140)
Abstract ORCID License
121.74 41
25 The use of coenzyme Q10 and DHEA during IUI and IVF cycles i… (10.3109/09513590.2015.1137095)
Abstract ORCID License
120.15 39
26 Effect of sleeve gastrectomy bariatric surgery-induced weigh… (10.3109/09513590.2016.1169267)
Abstract ORCID License
120.15 39
27 A comparative study of dydrogesterone and micronized progest… (10.3109/09513590.2015.1110136)
Abstract ORCID License
119.33 38
28 Effectiveness of estrogen treatment before transcervical res… (10.3109/09513590.2016.1160375)
Abstract ORCID License
119.33 38
29 How can we better predict the risk of spontaneous miscarriag… (10.3109/09513590.2015.1031103)
Abstract ORCID License
117.62 36
30 Drospirenone as estrogen-free pill and hemostasis: coagulato… (10.3109/09513590.2016.1161743)
Abstract ORCID License
117.62 36
31 The effect of vitamin D on primary dysmenorrhea with vitamin… (10.3109/09513590.2015.1136617)
Abstract ORCID License
116.72 35
32 Should pre-implantation genetic screening be implemented to… (10.3109/09513590.2016.1142962)
Abstract ORCID License
116.72 35
33 Attitudes on fertility issues in breast cancer patients: an… (10.3109/09513590.2014.1003293)
Abstract ORCID License
115.81 34
34 Association between serum adropin levels and gestational dia… (10.3109/09513590.2015.1081681)
Abstract ORCID License
115.81 34
35 Low antimullerian hormone levels may be associated with card… (10.3109/09513590.2015.1116065)
Abstract ORCID License
115.81 34
36 Postoperative administration of dienogest for suppressing re… (10.3109/09513590.2016.1147547)
Abstract ORCID License
115.81 34
37 Dienogest as preoperative treatment of submucous myomas for… (10.3109/09513590.2015.1128409)
Abstract ORCID License
114.86 33
38 Measures of body adiposity and visceral adiposity index as p… (10.3109/09513590.2015.1112785)
Abstract ORCID License
113.89 32
39 Aliskiren – a promising strategy for ovarian ischemia/reperf… (10.3109/09513590.2016.1153055)
Abstract ORCID License
113.89 32
40 Evaluation of circulating betatrophin levels in gestational… (10.3109/09513590.2015.1056142)
Abstract ORCID License
112.89 31
41 Comparison between follicular stimulation and luteal stimula… (10.3109/09513590.2015.1081683)
Abstract ORCID License
111.85 30
42 Gonadal malignancy in 202 female patients with disorders of… (10.3109/09513590.2015.1116509)
Abstract ORCID License
111.85 30
43 Surgical technique of endometrioma excision impacts on the o… (10.3109/09513590.2015.1017812)
Abstract ORCID License
109.68 28
44 Management of polycystic ovarian syndrome with Diane-35 or D… (10.3109/09513590.2015.1101441)
Abstract ORCID License
109.68 28
45 Histopathologic and metabolic effect of ursodeoxycholic acid… (10.3109/09513590.2015.1134478)
Abstract ORCID License
109.68 28
46 Obstetric and perinatal outcome from single cleavage transfe… (10.3109/09513590.2015.1006615)
Abstract ORCID License
108.54 27
47 Anti-Mullerian hormone trend evaluation after laparoscopic s… (10.3109/09513590.2015.1068754)
Abstract ORCID License
107.35 26
48 Are serum chemerin levels different between obese and non-ob… (10.3109/09513590.2015.1075501)
Abstract ORCID License
107.35 26
49 The effects of polycystic ovary syndrome on gestational diab… (10.3109/09513590.2015.1101438)
Abstract ORCID License
107.35 26
50 A comparison between the effects of metformin and<i>N</i>-ac… (10.3109/09513590.2015.1115974)
Abstract ORCID License
107.35 26